Top compounds associated with response to SYT9


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.009 0.8
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.009 0.8
mRNA phenformin GDSC1000 pan-cancer AAC 0.0069 0.8
mRNA Cyclopamine GDSC1000 pan-cancer AAC 0.012 0.8
mRNA VX-680 CTRPv2 pan-cancer AAC -0.022 0.8
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.0079 0.8
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.0069 0.8
mRNA WZ4002 CTRPv2 pan-cancer AAC 0.011 0.8
mRNA tivantinib CTRPv2 pan-cancer AAC 0.011 0.8
mRNA CHEMBL1222381 CTRPv2 pan-cancer AAC -0.0076 0.8
Download CSV